CVS Pharmacy Inc. and various subsidiaries have agreed to pay $315 million to resolve a Justice Department case alleging it unlawfully dispensed medically unnecessary prescriptions of highly addictive opioids. The settlement announced Tuesday resolves a lawsuit brought in 2024 that accused the healthcare giant of prescribing massive amounts of opioids and other controlled substances “to fuel its own profits at the expense of public health and safety.” It’s the latest effort by the federal government to hold accountable companies that officials have alleged helped fuel the U.S. addiction and overdose crisis.